Telomir Pharmaceuticals, Inc. · NASDAQ:TELO
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 5.17% stake in Telomir Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 5.17% stake in Telomir Pharmaceuticals, Inc., 3,554,871 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.17%
- Shares
- 3,554,871
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 5.17% | 3,554,871 |
Source
Related
- Telomir Pharmaceuticals, Inc.
- John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
- Telomir Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Feb 12, 2026
- Schedule 13G · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Sep 18, 2025
- Form 4 · Aminov Erez · Apr 24, 2026